ACI and CRN are excited to welcome you back to New York City this Spring for our 12th Legal, Regulatory & Compliance Forum on Dietary Supplements.
In Collaboration with the
Conference Co-Chairs
Megan Olsen
Senior Vice President & General Counsel
Council for Responsible Nutrition
Taneesha Routier
Director of Regulatory Affairs
XYMOGEN
Fireside Chat with the Federal Trade Commission
Christine DeLorme
Attorney, Division of Advertising Practices
Federal Trade Commission
Spotlight Interview
with
Cara Welch, Ph.D.
Director, Office of Dietary Supplement Programs
Center for Food Safety and Applied Nutrition
U.S. Food and Drug Administration
This Year’s Session Highlights
DSHEA Turns 30 – Examining the DSHEA of Today and Projections for the DSHEA of Tomorrow: Think Tank on Combatting Bad Actors and Fostering Responsible Industry
Spotlight Interview with FDA: Assessing the Full Impact of the FDA Reorganization on the Dietary Supplements Industry
FDA Activity Round-Up: Forecasts for the Future of NDIs, Healthy Claims, IND Requirements and More
Analyzing New State Laws and Legislation Impacting Supplements – Age Restrictions, Ingredient Bans and More
Formulating Strategies to Insulate Yourself from the Latest Dietary Supplement Class Action Activity
Critical Takeaways from the Latest Dietary Supplement Advertising Decisions Issued by the National Advertising Division (NAD)
Regulation by Retailer: Adhering to the Latest Testing and Labeling Requirements of Amazon, CVS and Other Dietary Supplement Retailers
A Must Attend Event For
Dietary Supplement Industry Representatives:
In-House Counsel, including generalists and those having responsibility for FDA and FTC compliance and regulatory affairs as well as:
- Advertising and Promotion
- IP, Patents and Trademarks
- Licensing and Business Development
Officers, Directors and Executives for Regulatory Affairs and Business Development
Law Firm Attorneys for the Dietary Supplement Industry whose practices focus on:
- FDA and FTC law
- Advertising and Promotion
- Trademarks, Patents and IP
CLE Accreditation
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
“I really enjoyed the ability to interact, converse and network with the speakers as well as the other attendees to discuss their experiences and knowledge in these areas of the Supplements industry. The wide range of topics and knowledge was impressive.”
“As a member of a dietary supplement regulatory affairs department reviewing product content daily for FTC / FDA compliance, it was a valuable experience to be in a room with top minds from around the country who could answer my questions.”
“I appreciated the attention to urgent regulatory concerns, the application to personalized nutrition, and specifically — how each presenter tied it back to what companies can do to protect themselves and the industry.”
“Great content! It reinforced what I understood about the connection of regulations and litigation, while increasing my knowledge of quality and FDA audits.”
Manager, Unilever
“Awesome opportunity to learn first-hand knowledge from those with expertise in the field of Dietary Supplements.”
“Comprehensive and in-depth review of leading regulatory issues for the dietary supplement industry.”
Upcoming Related Conferences
